Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Select biomarkers for tumors of the gastrointestinal tract: present and future.

Archives of pathology & laboratory medicine - 1 Apr 2015

Bartley Angela N, Hamilton Stanley R

Abstract excerpt

CONTEXT: Advances in molecular biomarkers of the gastrointestinal tract have contributed to a decline in the incidence of and mortality from diseases of the gastrointestinal tract. The discovery and clinical validation of new biomarkers are important to personalized cancer therapy, and numerous clinical trials are currently ongoing to help identify individualized therapy affecting these biomarkers and molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Forecasting
Share to Gastrointestinal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Precision Medicine

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 25333834
DOI: 10.5858/arpa.2014-0189-RA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Select biomarkers for tumors of the gastrointestinal tract: present and future.PMID 25333834Read ↗

Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona.Semantic proximity Read ↗

The current state of molecular profiling in gastrointestinal malignancies.Semantic proximity Read ↗

Molecular targets in GI malignancies - A pathologist's perspective.Semantic proximity Read ↗

Tumors of the Digestive System: Comprehensive Review of Ancillary Testing and Biomarkers in the Era of Precision Medicine.Semantic proximity Read ↗

Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinomaSemantic proximity Read ↗

Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.Semantic proximity Read ↗

Molecular markers of pancreatic cancer: development and clinical relevanceSemantic proximity Read ↗

Novel Biomarkers in the Diagnosis of Benign and Malignant Gastrointestinal DiseasesSemantic proximity Read ↗

The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.Semantic proximity Read ↗

Molecular subtypes in cancers of the gastrointestinal tract.Semantic proximity Read ↗

Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectivesSemantic proximity Read ↗

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.